bb2121
bms
['mmsm', 'karmma', 'cart,(-cartitude)']
congress #asco22 | ide-cel in real-world patients. poster presented by doris hansen should #cart eligibility be guided by trial criteria? 77% of the patients included in this analysis wouldn t be eligible for the karmma trial #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma